European sales and use of antimicrobials for veterinary medicine: Annual surveillance report for 2024
3-year work plan for the joint CHMP/CVMP Quality Working Party 2026-2028
Consolidated 3-year rolling work plan for the Non-clinical domain 2026-2028
Questions and answers for biological medicinal products
New Approach Methodologies EU-IN Horizon Scanning Report
3-year rolling work plan for the Biosimilar Medicinal Products Working Party 2026-2028
Alzheimer’s disease EU-IN Horizon Scanning Report
3-year work plan for the Biologics Working Party (BWP) 2026-2028
Human medicines European public assessment report (EPAR): Aubagio, teriflunomide, Date of authorisation: 26/08/2013, Revision: 30, Status: Authorised
Guideline on the development and manufacture of synthetic peptides